You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
石四藥集團(02005.HK):取得核酸提取或純化試劑註冊及生產備案憑證,將進行生產及掛網銷售
格隆匯 05-24 18:09

格隆匯5月24日丨石四藥集團(02005.HK)發佈公告,集團附屬公司河北翰林生物科技有限公司已取得石家莊市行政審批局有關第一類體外診斷試劑:核酸提取或純化試劑的註冊及生產備案憑證,將進行生產及掛網銷售。

該產品主要用於核酸的提取、富集、純化等步驟,其處理後的產物主要在臨牀體外檢測中使用。該產品適用於咽拭子、鼻咽拭子、痰液、唾液、血漿、血清、尿液、糞便等樣品進行核酸提取,不僅應用於新冠核酸的提取,也適用於其他(除組織外)的核酸提取。該產品針對小量體積的病毒核酸提取,具有便宜、高效、穩定、簡便等特點。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account